Rifamail 150 Capsule contains Rifampicin 150mg, a first-line anti-tuberculosis agent used in the treatment of TB and other bacterial infections. It helps in eradicating Mycobacterium tuberculosis and preventing disease progression.
Rifampicin works by inhibiting bacterial RNA polymerase, thereby suppressing bacterial protein synthesis and promoting rapid microbial clearance. Its effectiveness in combination therapy makes it a cornerstone in TB treatment protocols.
Capsule formulation ensures accurate dosing, stable bioavailability, and convenient administration, enhancing patient adherence. Due to its critical role in TB management, Rifamail 150 Capsule maintains consistent demand in hospitals, clinics, and government health programs.
Adding Rifamail 150 Capsule to your anti-tuberculosis and anti-infective portfolio strengthens your product range with a high-rotation, trusted molecule. Its prescriber confidence, institutional use, and export potential make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.
Common side effects may include nausea, vomiting, abdominal discomfort, loss of appetite, or mild diarrhea. Rare but serious side effects include liver function abnormalities, allergic reactions, orange-red discoloration of body fluids, or thrombocytopenia. Patients should seek immediate medical attention if severe or persistent symptoms occur.
Rifamail 150 Capsule is indicated for the treatment of tuberculosis, leprosy, and other infections caused by susceptible Mycobacterium species, as part of combination therapy prescribed by a healthcare professional.
Rifamail 150 Capsule should be taken exactly as prescribed, preferably on an empty stomach, to ensure maximum absorption. Complete the full course of therapy to prevent resistance. Inform the doctor of any history of liver disease, kidney problems, or other concurrent medications.
Store Rifamail 150 Capsule in a cool, dry place away from direct sunlight. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.